Literature DB >> 30683984

The functional roles of exosomal long non-coding RNAs in cancer.

Man Wang1, Li Zhou2, Fei Yu3, Yinfeng Zhang3, Peifeng Li3, Kun Wang4.   

Abstract

Exosomes are extracellular membranous vesicles that are secreted by various cell types. Exosomes have become indispensable facilitators in the exchange of information between cells. More importantly, exosomes perform a crucial role in a variety of diseases including cancers. Long non-coding RNAs (lncRNAs) are over 200 nucleotides long transcripts that exhibit no or limited protein-coding potentials. LncRNAs are an emerging group of regulatory RNAs and can be selectively packaged into exosomes. Exosomal lncRNAs play a central role in carcinogenesis and cancer progression by modulating tumor growth, metastasis, angiogenesis and chemoresistance. Moreover, exosomal lncRNAs function as messengers in cell-to-cell communication, and thus remodel the tumor microenvironment. Their function relevance in cancer biology hints at the possibility of employing exosomal lncRNAs as promising, non-invasive biomarkers for further cancer therapy. In this review, we provide an overview of current research on the functional roles of exosomal lncRNAs in cancer and discuss their potential clinical applications as diagnostic biomarkers and therapeutic targets for cancers.

Entities:  

Keywords:  Cancer diagnosis; Cancer pathogenesis; Cancer therapy; Exosome biogenesis; Exosomes; Extracellular vesicles; Long non-coding RNA

Mesh:

Substances:

Year:  2019        PMID: 30683984     DOI: 10.1007/s00018-019-03018-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  136 in total

Review 1.  Epigenetic gene regulation by noncoding RNAs.

Authors:  Angela A Andersen; Barbara Panning
Journal:  Curr Opin Cell Biol       Date:  2003-06       Impact factor: 8.382

2.  Environmental protection: studies highlight importance of tumor microenvironment.

Authors:  Karyn Hede
Journal:  J Natl Cancer Inst       Date:  2004-08-04       Impact factor: 13.506

Review 3.  Exosome secretion: the art of reutilizing nonrecycled proteins?

Authors:  Aude de Gassart; Charles Géminard; Dick Hoekstra; Michel Vidal
Journal:  Traffic       Date:  2004-11       Impact factor: 6.215

4.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

Authors:  Wei Zhu; Wenrong Xu; Runqiu Jiang; Hui Qian; Miao Chen; Jiabo Hu; Weike Cao; Chongxu Han; Yongchang Chen
Journal:  Exp Mol Pathol       Date:  2005-10-07       Impact factor: 3.362

5.  Exosomal-like vesicles are present in human blood plasma.

Authors:  Marie-Pierre Caby; Danielle Lankar; Claude Vincendeau-Scherrer; Graça Raposo; Christian Bonnerot
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

Review 6.  Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.

Authors:  Nicola Giuliani; Vittorio Rizzoli; G David Roodman
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

7.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

8.  Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis.

Authors:  Atsushi Inoue; Shinya Y Sawata; Kazunari Taira; Renu Wadhwa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-04       Impact factor: 11.205

9.  Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

Authors:  Marc Schmidt; Silvia Fernandez de Mattos; Armando van der Horst; Rob Klompmaker; Geert J P L Kops; Eric W-F Lam; Boudewijn M T Burgering; René H Medema
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

10.  Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa.

Authors:  K Klimek-Tomczak; M Mikula; A Dzwonek; A Paziewska; J Karczmarski; E Hennig; J M Bujnicki; P Bragoszewski; O Denisenko; K Bomsztyk; J Ostrowski
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more
  35 in total

Review 1.  Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-22       Impact factor: 3.727

2.  Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.

Authors:  Deyao Shi; Shidai Mu; Feifei Pu; Binlong Zhong; Binwu Hu; Muradil Muhtar; Wei Tong; Zengwu Shao; Zhicai Zhang; Jianxiang Liu
Journal:  Cell Mol Life Sci       Date:  2022-07-16       Impact factor: 9.207

3.  Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.

Authors:  Hong Gao; Xiaosong Sun; Hongdong Wang; Ying Zheng
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

4.  Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.

Authors:  Ji-Fu Zheng; Ning-Hong Guo; Fu-Ming Zi; Jing Cheng
Journal:  Mol Cell Biol       Date:  2020-01-16       Impact factor: 4.272

Review 5.  Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.

Authors:  Jian Cheng; Jinli Meng; Lei Zhu; Yong Peng
Journal:  Mol Cancer       Date:  2020-03-25       Impact factor: 27.401

6.  UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma.

Authors:  Wu Xu; Dan-Dan Che; Liang Chen; Sheng-Qing Lv; Jun Su; Jun Tan; Qing Liu; Ya-Wen Pan
Journal:  J Mol Neurosci       Date:  2021-02-02       Impact factor: 3.444

Review 7.  Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets.

Authors:  Sung-Hyun Kim; Key-Hwan Lim; Sumin Yang; Jae-Yeol Joo
Journal:  J Hematol Oncol       Date:  2021-05-12       Impact factor: 17.388

Review 8.  Decoding LncRNAs.

Authors:  Lidia Borkiewicz; Joanna Kalafut; Karolina Dudziak; Alicja Przybyszewska-Podstawka; Ilona Telejko
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 9.  Tumor-Derived Exosomes in Immunosuppression and Immunotherapy.

Authors:  Wioletta Olejarz; Agnieszka Dominiak; Aleksandra Żołnierzak; Grażyna Kubiak-Tomaszewska; Tomasz Lorenc
Journal:  J Immunol Res       Date:  2020-05-22       Impact factor: 4.818

10.  Protective effect of bone marrow mesenchymal stem cell-derived exosomes against the reproductive toxicity of cyclophosphamide is associated with the p38MAPK/ERK and AKT signaling pathways.

Authors:  Xiao-Bin Guo; Jia-Wen Zhai; Hui Xia; Jian-Kun Yang; Jun-Hao Zhou; Wen-Bin Guo; Cheng Yang; Ming Xia; Kang-Yi Xue; Cun-Dong Liu; Qi-Zhao Zhou
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.